JPWO2020205499A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020205499A5 JPWO2020205499A5 JP2021557383A JP2021557383A JPWO2020205499A5 JP WO2020205499 A5 JPWO2020205499 A5 JP WO2020205499A5 JP 2021557383 A JP2021557383 A JP 2021557383A JP 2021557383 A JP2021557383 A JP 2021557383A JP WO2020205499 A5 JPWO2020205499 A5 JP WO2020205499A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825983P | 2019-03-29 | 2019-03-29 | |
| US62/825,983 | 2019-03-29 | ||
| PCT/US2020/025181 WO2020205499A1 (en) | 2019-03-29 | 2020-03-27 | Engineered variant antibodies that bind cd38 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022527084A JP2022527084A (ja) | 2022-05-30 |
| JPWO2020205499A5 true JPWO2020205499A5 (https=) | 2023-02-16 |
| JP2022527084A5 JP2022527084A5 (https=) | 2023-02-16 |
| JP7555953B2 JP7555953B2 (ja) | 2024-09-25 |
Family
ID=72666916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557383A Active JP7555953B2 (ja) | 2019-03-29 | 2020-03-27 | Ｃｄ３８に結合する操作されたバリアント抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220144966A1 (https=) |
| EP (1) | EP3947465A4 (https=) |
| JP (1) | JP7555953B2 (https=) |
| CN (2) | CN114524877A (https=) |
| CA (1) | CA3134612A1 (https=) |
| WO (1) | WO2020205499A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112313250B (zh) * | 2018-06-20 | 2024-10-01 | 索伦托药业有限公司 | 结合cd38的变体抗体 |
| CN114516918B (zh) * | 2022-03-04 | 2022-09-27 | 四川大学华西医院 | 一种抗体及其应用 |
| CN114409788B (zh) * | 2022-03-04 | 2022-10-04 | 四川大学华西医院 | 抗cd38的抗体及其应用 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| CN120607617A (zh) * | 2024-03-07 | 2025-09-09 | 宜明昂科生物医药技术（上海）股份有限公司 | 靶向cd38和cd47的重组融合蛋白 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7413737B2 (en) * | 2003-11-14 | 2008-08-19 | Massachusetts Institute Of Technology | Anti-hydroxylase antibodies and uses thereof |
| EP2567976B1 (en) * | 2005-03-23 | 2017-07-19 | Genmab A/S | Antibodies against CD38 for treatment of multiple myeloma |
| US20090258005A1 (en) * | 2007-05-29 | 2009-10-15 | Trubion Pharmaceuticals Inc. | Therapeutic compositions and methods |
| JOP20210044A1 (ar) * | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| GB201503812D0 (en) * | 2015-03-06 | 2015-04-22 | Univ Aberdeen | Antibody molecules and uses thereof |
| ES2927119T3 (es) * | 2015-04-08 | 2022-11-02 | Sorrento Therapeutics Inc | Productos terapéuticos de anticuerpos que se unen a CD38 |
| JP6971231B2 (ja) * | 2015-11-17 | 2021-11-24 | グローバル・バイオエナジーズ | ３−メチルクロトン酸からイソブテンを製造する方法 |
| KR102719065B1 (ko) * | 2017-06-08 | 2024-10-17 | 블랙 벨트 테라퓨틱스 리미티드 | Cd38 조정 항체 |
| KR102771835B1 (ko) * | 2017-06-20 | 2025-02-26 | 비바솔, 인코포레이티드. | Cd38 항체 약물 접합체 |
| CN112313250B (zh) * | 2018-06-20 | 2024-10-01 | 索伦托药业有限公司 | 结合cd38的变体抗体 |
-
2020
- 2020-03-27 JP JP2021557383A patent/JP7555953B2/ja active Active
- 2020-03-27 EP EP20784030.7A patent/EP3947465A4/en not_active Withdrawn
- 2020-03-27 US US17/599,377 patent/US20220144966A1/en not_active Abandoned
- 2020-03-27 CA CA3134612A patent/CA3134612A1/en active Pending
- 2020-03-27 WO PCT/US2020/025181 patent/WO2020205499A1/en not_active Ceased
- 2020-03-27 CN CN202210168939.3A patent/CN114524877A/zh active Pending
- 2020-03-27 CN CN202080040061.4A patent/CN113939537A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP7425604B2 (ja) | 抗ｃｔｌａ４－抗ｐｄ－１二機能性抗体、その医薬組成物および使用 | |
| KR102340832B1 (ko) | 항 pd-1 항체 및 그의 용도 | |
| TWI821474B (zh) | Ｃｄ３抗體及其藥物用途 | |
| JP6480907B2 (ja) | 多量体化技術 | |
| TWI804572B (zh) | 雙特異性抗體 | |
| JP2023099051A (ja) | Ｉｌ２ｒベータ／共通ガンマ鎖抗体 | |
| EP3691663A2 (en) | Methods of treating immunotherapy-related toxicity using a gm-csf antagonist | |
| CN107922484A (zh) | 结合tim3的抗体治疗剂 | |
| JP7688805B2 (ja) | 二重特異性抗体 | |
| US20230192861A1 (en) | Anti-pd-l1/anti-b7-h3 multispecific antibodies and uses thereof | |
| JP2023179541A (ja) | Ｃｄ３結合分子 | |
| JP7574692B2 (ja) | 二重特異性抗体 | |
| JPWO2020205499A5 (https=) | ||
| JPWO2020176549A5 (https=) | ||
| JP2025540657A (ja) | 抗ｃｄ３抗体 | |
| RU2021128015A (ru) | Антигенсвязывающие белки, которые связываются с bcma | |
| JPWO2020218951A5 (https=) | ||
| US20240084026A1 (en) | Anti-4-1bb antibodies and methods of making and using thereof | |
| JP7714992B2 (ja) | 二重特異性抗体を有効成分として含む医薬組成物 | |
| US20250368740A1 (en) | Multifunctional recombinant antibody, preparation method and use thereof | |
| CA3125451C (en) | Cd137 agonist antibodies and uses thereof |